Lobe-Specific Lymph Node Dissection May be Feasible for Clinical N0 Solid-Predominant Part-Solid Lung Adenocarcinoma

Yang Wo1, Hang Li1, Zhencong Chen2

  • 1Department of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China; Institute of Thoracic Oncology, Fudan University, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.

Clinical Lung Cancer
|April 7, 2023
PubMed
Summary

Lymph node metastasis occurs in 10% of solid-predominant part-solid nodules (PSNs). Lobe-specific lymph node dissection (LND) may be safe for PSNs with solid components ≤ 2 cm, but systematic LND is advised otherwise.

Related Concept Videos